On May 9, 2017, the Federal Circuit gave Finnegan client Nestle a second chance to challenge Steuben Foods Inc.'s patent on bacteria-free bottling. The court vacated and remanded the Patent Trial and Appeal Board's (PTAB) ruling that Steuben Foods' patent is valid. The determination of the patent's validity is dependent upon the level of how "aseptic" bottles have to be before they are filled. The Federal Circuit agreed with Nestle that the FDA had clear regulations related to packaging and remanded the case for a validity determination in line with Nestle's preferred interpretation.
United States Court of Appeals for the Federal Circuit (CAFC), Food and Drug Administration (FDA)
Award/Ranking
Finnegan Named Firm of the Year at the 2024 Managing Intellectual Property Americas Awards
April 26, 2024
Commentary
World IP Day: EPO Reveals 33% Jump in Cleantech Inventions Over Five Years
April 26, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.